MacKay BJ, McCormack RA, Blank AT, Bettiol P, Cox C, Brindley G, Rapp TB. Diagnosis and management of primary malignant tumors in the upper extremity. Orthop Rev (Pavia). 2021; 2035–8237 (Print).

von Mehren M, Kane JM, Agulnik M, Bui MM, Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ, Holder A, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Mesko NW, Meyer C, Pappo AS, Parkes AM, Petersen IA, Pollack SM, Poppe M, Riedel RF, Schuetze S, Shabason J, Sicklick JK, Spraker MB, Zimel M, Hang LE, Sundar H, Bergman MA (2022) Soft tissue sarcoma, Version 2.2022 NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 20(7):815–833

Article  Google Scholar 

Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12–49

Article  PubMed  Google Scholar 

Saebye C, Amidi A, Keller J, Andersen H, Baad-Hansen T (2020) Changes in functional outcome and quality of life in soft tissue sarcoma patients within the first year after surgery: a prospective observational study. Cancers (Basel) 12(2):463

Article  PubMed  Google Scholar 

Wisanuyotin T, Sirichativapee W, Sumnanoont C, Paholpak P, Laupattarakasem P, Sukhonthamarn K, Kosuwon W (2018) Prognostic and risk factors in patients with metastatic bone disease of an upper extremity. J Bone Oncol 13(2212–1366 (print)):71–75

Article  PubMed  PubMed Central  Google Scholar 

Weeks JC, Cook EF, O’Day SJ, Peterson LM, Wenger N, Reding D, Harrell FE, Kussin P, Dawson NV, Connors JAF, Lynn J, Phillips RS (1998) Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 279(21):1709–1714

Article  PubMed  CAS  Google Scholar 

Jones JA, Lutz ST, Chow E, Johnstone PA (2014) Palliative radiotherapy at the end of life: a critical review. CA Cancer J Clin 64(5):296–310

Article  PubMed  Google Scholar 

Ehresman J, Lubelski D, Pennington Z, Hung B, Ahmed AK, Azad TD, Lehner K, Feghali J, Buser Z, Harrop J, Wilson J, Kurpad S, Ghogawala Z, Sciubba DM (2021) Utility of prediction model score: a proposed tool to standardize the performance and generalizability of clinical predictive models based on systematic review. J Neurosurg Spine 34(5):779–787

Article  PubMed  Google Scholar 

Karhade AV, Thio Q, Ogink PT, Shah AA, Bono CM, Oh KS, Saylor PJ, Schoenfeld AJ, Shin JH, Harris MB, Schwab JH (2019) Development of machine learning algorithms for prediction of 30-day mortality after surgery for spinal metastasis. Neurosurgery 85(1):E83–E91

Article  PubMed  Google Scholar 

Matthew JP, Joanne EM, Patrick MB, Isabelle B, Tammy CH, Cynthia DM, Larissa S, Jennifer MT, Elie AA, Sue EB, Roger C, Julie G, Jeremy MG, Asbjørn HB, Manoj ML, Tianjing L, Elizabeth WL, Evan MW, Steve M, Luke AM, Lesley AS, James T, Andrea CT, Vivian AW, Penny W, David M (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71

Google Scholar 

Sørensen MS, Gerds TA, Hindsø K, Petersen MM (2018) External validation and optimization of the spring model for prediction of survival after surgical treatment of bone metastases of the extremities. Clin Orthop Relat Res (1528–1132 (Electronic))

Forsberg JA, Eberhardt J, Boland PJ, Wedin R, Healey JH (2011) Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief network. PLoS ONE (1932–6203 (Electronic))

Tseng TE, Lee CC, Yen HK, Groot OQ, Hou CH, Lin SY, Bongers MER, Hu MH, Karhade AV, Ko JC, Lai YH, Yang JJ, Verlaan JJ, Yang RS, Schwab JH, Lin WH (2022) International validation of the SORG machine-learning algorithm for predicting the survival of patients with extremity metastases undergoing surgical treatment. Clin Orthop Relat Res 480(2):367–378

Article  PubMed  Google Scholar 

Lewis JJ, Leung D, Casper ES, Woodruff J, Hajdu SI, Brennan MF (1999) Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma. Arch Surg (0004–0010 (Print))

Lee DW, Kim HS, Han IAO (2021) Actual long-term survival after resection of stage III soft tissue sarcoma. BMC Cancer (1471–2407 (Electronic))

Janssen SJ, van der Heijden AS, van Dijke M, Ready JE, Raskin KA, Ferrone ML, Hornicek FJ, Schwab JH (2015) 2015 Marshall Urist young investigator award: prognostication in patients with long bone metastases: does a boosting algorithm improve survival estimates? Clin Orthop Relat Res 473(10):3112–3121

Article  PubMed  PubMed Central  Google Scholar 

Errani C, Cosentino M, Ciani G, Ferra L, Alfaro PA, Bordini B, Donati DM (2021) C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases. Int Orthop 45(5):1337–1346

Article  PubMed  Google Scholar 

Alcorn SR, Fiksel J, Wright JL, Elledge CR, Smith TJ, Perng P, Saleemi S, McNutt TR, DeWeese TL, Zeger S (2020) Developing an improved statistical approach for survival estimation in bone metastases management: the bone metastases ensemble trees for survival (BMETS) model. Int J Radiat Oncol Biol Phys 108(3):554–563

Article  PubMed  PubMed Central  Google Scholar 

Thio Q, Karhade AV, Bindels BJJ, Ogink PT, Bramer JAM, Ferrone ML, Caldero SL, Raskin KA, Schwab JH (2020) Development and internal validation of machine learning algorithms for preoperative survival prediction of extremity metastatic disease. Clin Orthop Relat Res (1528–1132 (Electronic))

Skalitzky MK, Gulbrandsen TR, Groot OQ, Karhade AV, Verlaan JJ, Schwab JH, Miller BJ (2022) The preoperative machine learning algorithm for extremity metastatic disease can predict 90-day and 1-year survival: an external validation study. J Surg Oncol 125(2):282–289

Article  PubMed  Google Scholar 

Smolle MAO, Musser E, Bergovec M, Friesenbichler J, Wibmer CL, Leitner LAO, Sorensen MAO, Petersen MM, Brcic IAO, Szkandera J, Scheipl S, Leithner AAO (2022) Survival prediction in patients treated surgically for metastases of the appendicular skeleton-an external validation of 2013-SPRING model. Cancers (Basel) (2072–6694 (Print))

Li W, Dong Y, Liu W, Tang Z, Sun C, Lowe S, Chen S, Bentley R, Zhou Q, Xu C, Li W, Wang B, Wang H, Dong S, Hu Z, Liu Q, Cai X, Feng X, Zhao W, Yin C (2022) A deep belief network-based clinical decision system for patients with osteosarcoma. Front Immunol (1664–3224 (Electronic))

Li W, Wang G, Wu R, Dong S, Wang H, Xu C, Wang B, Li W, Hu Z, Chen Q, Yin C (2022) Dynamic predictive models with visualized machine learning for assessing chondrosarcoma overall survival. Front Oncol 12:880305

Article  PubMed  PubMed Central  Google Scholar 

Li W, Jin G, Wu H, Wu R, Xu C, Wang B, Liu Q, Hu Z, Wang H, Dong S, Tang ZR, Peng H, Zhao W, Yin C (2022) Interpretable clinical visualization model for prediction of prognosis in osteosarcoma: a large cohort data study. Front Oncol 12:945362

Article  PubMed  PubMed Central  Google Scholar 

Thio Q, Karhade AV, Ogink PT, Raskin KA, De Amorim Bernstein K, Lozano Calderon SA, Schwab JH (2018) Can machine-learning techniques be used for 5-year survival prediction of patients with chondrosarcoma? Clin Orthop Relat Res 476(10):2040–2048

Article  PubMed  PubMed Central  Google Scholar 

Bongers MER, Thio Q, Karhade AV, Stor ML, Raskin KA, Lozano Calderon SA, Delaney TF, Ferrone ML, Schwab JH (2019) Does the SORG algorithm predict 5-year survival in patients with chondrosarcoma an external validation. Clin Orthop Relat Res 477(10):2296–2303

Article  PubMed  PubMed Central  Google Scholar 

Bongers MER, Karhade AV, Setola E, Gambarotti M, Groot OQ, Erdogan KE, Picci P, Donati DM, Schwab JH, Palmerini E (2020) How does the skeletal oncology research group algorithm’s prediction of 5-year survival in patients with chondrosarcoma perform on international validation? Clin Orthop Relat Res 478(10):2300–2308

Article  PubMed  PubMed Central  Google Scholar 

Lewin J, Puri A, Quek R, Ngan R, Alcasabas AP, Wood D, Thomas D (2013) Management of sarcoma in the Asia-Pacific region: resource-stratified guidelines. Lancet Oncol (1474–5488 (Electronic))

Poon E, Quek R (2018) Soft tissue sarcoma in Asia, Chin Clin Oncol (2304–3873 (Electronic))

Vandenbroucke JP (2008) Observational research, randomised trials, and two views of medical science, PLoS Med (1549–1676 (Electronic))

Euser AM, Zoccali C, Jager KJ, Dekker FW (2009) Cohort studies: prospective versus retrospective. Nephron Clin Pract (1660–2110 (Electronic))

Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW (2016) A calibration hierarchy for risk models was defined: from utopia to empirical data. J Clin Epidemiol (1878–5921 (Electronic))

Manolio TA, Weis BK, Cowie CC, Hoover RN, Hudson K, Kramer BS, Berg C, Collins R, Ewart W, Gaziano JM, Hirschfeld S, Marcus PM, Masys D, McCarty CA, McLaughlin J, Patel AV, Peakman T, Pedersen NL, Schaefer C, Scott JA, Sprosen T, Walport M, Collins FS (2012) New models for large prospective studies: is there a better way?, Am J Epidemiol (1476–6256 (Electronic))

Siontis GC, Tzoulaki I, Castaldi PJ, Ioannidis JP (2015) External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. J Clin Epidemiol (1878–5921 (Electronic))

Collins GS, de Groot JA, Dutton S, Omar O, Shanyinde M, Tajar A, Voysey M, Wharton R, Yu L-M, Moons KG, Altman DG (2014) External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol 14(1):40

Article  PubMed  PubMed Central  Google Scholar 

Vergouwe Y, Steyerberg EW, Eijkemans MJC, Habbema JDF (2005) Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol (0895–4356 (Print))

Lee YAO, Bang H, Kim DAO (2016) How to establish clinical prediction models. Endocrinol Metab (Seoul) (2093–596X (Print))

Steyerberg EW, Vergouwe Y (2014) Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J (1522–9645 (Electronic))

Altman DG, Vergouwe Y, Royston P, Moons KGM (2009) Prognosis and prognostic research: validating a prognostic model. BMJ 338:b605

Article  PubMed  Google Scholar 

Moons KGM, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, Woodward M (2012) Risk prediction models: II. External validation, model updating, and impact assessment. Heart 98(9):691–698

Article  PubMed  Google Scholar 

Bleeker SE, Moll HA, Steyerberg EW, Donders AR, Derksen-Lubsen G, Grobbee DE, Moons KG (2003) External validation is necessary in prediction research: a clinical example. J Clin Epidemiol (0895–4356 (Print))

Justice AC, Covinsky KE, Berlin JA (1999) Berlin, Assessing the generalizability of prognostic information. Ann Intern Med. (0003–4819 (Print))

Pisters PWT, Weiss M, Maki R, Haller DG, Wagman LD, Camphausen C, Hoskins WJ (2011) Cancer management: a multidisciplinary approach medical, surgical & radiation oncology, 14th edn. UBM Medica LLC

Google Scholar 

Lawrenz JAO, Johnson SR, Hajdu KS, Chi A, Bendfeldt GAO, Kang H, Halpern JL, Holt GE, Schwartz HS (2023) Is the number of national database research studies in musculoskeletal sarcoma increasing, and are these studies reliable? Clin Orthop Relat Res (1528–1132 (Electronic))

Talari K, Goyal M (2020) Retrospective studies—Utility and caveats. J R Coll Physicians Edinb (2042–8189 (Electronic))

de Groot TM, Ramsey D, Groot OQ, Fourman MAO, Karhade AV, Twining PK, Berner EA, Fenn BP, Collins AAO, Raskin K, Lozano SAO, Newman E, Ferrone M, Doornberg JN, Schwab JH (2023) Does the SORG machine-learning algorithm for extremity metastases generalize to a contemporary cohort of patients? Temporal validation from 2016 to 2020. Clin Orthop Relat Res (1528–1132 (Electronic))

Gronchi A, Miceli R, Shurell E, Eilber FC, Eilber FR, Anaya DA, Kattan MW, Honoré C, Lev DC, Colombo C, Bonvalot S, Mariani L, Pollock RE (2013) Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol (1527–7755 (Electronic))

Kattan MW, Leung DHY, Brennan MF (2002) Postoperative nomogram for 12-year sarcoma-specific death, J Clin Oncol (0732–183X (Print))